CC BY
27
https://doi.org/10.35805/BSK2022IV040
NagasbekovM.S.
orcid.org/0000-0003-3355-8679 Baimakhanov Zh.B. orcid.org/0000-0002-2682-5591 Nurlanbayev E.K. orcid.org/0000-0001-8758-5061 Kaniyev Sh.A.
orcid.org/0000-0002-1288-0987 Chormanov A.T. orcid.org/0000-0003-3513-1935 Baimakhanov B.B. orcid.org/0000-0003-0049-5886
Corresponding author. Nagasbekov M.S. - PhD student, "A.N. Syzganov NSCS" JSC, Almaty, Kazakhstan E-mail: nagasbekov@inbox.ru
Conflict of interest
The authors declare that they have no conflicts of interest
Keywords:
echinococcal cyst, liver hidatidosis, PAIR, Albendazol, pericystectomy
MODERN APPROACHES IN THE DIAGNOSTICS AND TREATMENT OF CYSTIC LIVER ECHINOCOCCOSIS. LITERATURE REvIEW
Nagasbekov M.S.12, Baimakhanov Zh.B.12, Nurlanbayev E.K.12, Kaniyev Sh. A.12, Chormanov A.T. 12, Baimakhanov B.B.12
1 «A.N. Syzganov National Scientific Center of Surgery» JSC, Almaty, Kazakhstan
2 «S.D. Asfendiyarov Kazakh National Medical University», NC JSC, Almaty, Kazakhstan
Abstract
Liver echinococcosis is a severe zoonotic disease of cosmopolitan nature caused by cestodes of the genus Echinococcus from the family Taeniidae that leads to cystic and alveolar echinococcosis that forms a significant problem in public health worldwide.
The purpose of this work is to analyze a literature review of modern approaches in the diagnostics and treatment of liver cystous echinococcosis
Material and methods. We systematically searched the literature and selected sources from MEDLINE, PubMed, Scopus, Elsevier, E-library, Google Scholar as well as research papers and online educational publications in various languages. Forty three papers that met the inclusion criteria were included.
Results. The review article presents epidemiology, methods of diagnosis and treatment of cystic liver echinococcus.
Conclusion. Thus, among the modern approaches in diagnostics of cystic liver echinococcosis, ultrasound is the method of choice, also CT, MRI, ERCP are methods used for identifying complications. Morever, various surgical methods in combination with antiparasitic therapy decrease the risk and recurrence of cystic liver echinococcosis.
Бауырдьщ кистозды эхинококкозын аныртау мен емдеудщ Ka3ipri заманауи тэсшдерк Эдебиет шолуы.
Хат алысатын автор. Нагасбеков М.С. - PhD докторант, «АН. Сызганое ат. YFXO» АН, Алматы ;., Наза;стан E-mail: nagasbekov@inbox.ru
Мудделер ¡ацтыгысы
Аеторлар MYдделер ^а^тыгысыныц жо^тыгын мэлiмдейдi
Туйш сездер:
эхинококкоз кистасы, бауыр гидатидозы, PAIR, Альбендазол, перицистэктомия.
Нагасбеков М.С.1,2, Баймаханов Ж.Б.1,2, Нурланбаев Е.К.1,2, Каниев Ш.А.1,2, Чорманов А.Т. 12, Баймаханов Ж.Б.1,2
1 «А. Н. Сызганов атындагы ¥лтты^ гылыми хирургия орталыгы» А^, Алматы ^аза^стан Республикасы
2 «С. Ж. Асфендияров атындагы ^аза^ ¥лттьщ медицина университет^ Ке А^, Алматы ^аза^стан Республикасы
Ацдатпа
Бауыр эхинококкозы - космополитикалы; сипаттагы ауыр зоонозды ауру, taeniidae ту;ымдасыныц Echinococcus цестодтарынан туындайды, жэне де кистозды жэне альееолярлы эхинококкозга шалды;тыратын бул ауру бу.юл элем бойынша денсаулы; са;тауы саласындагы езектi мэселе болып табылады.
Жумыстыц мацсаты - бауырдыц кистозды эхинококкозын диагностикалау мен емдеудiц заманауи тэс'шдер'ше эдеби шолу.
Материал жэне эдстер. Б'з жYйелi тYрде эдебиеттерд'1 '¡здед'к жэне MEDLINE, PubMed, Scopus, Elsevier, E-library, Google Scholar дереккездерн, сондай-а; эртYрлi тлдердегi зерттеу жумыстары мен онлайн б'ш'м беру басылымдарын тацдадыНосылу критерийлерiне сэйкес келетн ;ыры; Yш ;ужат енг1з1лд1.
Нэтижелер. Бул ма;алада бауыр эхинококкыныц эпидемиологиясы, диагностикасы жэне емдеу эдстер берлген.
Цорытынды. Осылайша, бауырдыц кистозды эхинококкозын диагностикалаудагы заманауи эдстердц шнде УДЗ тацдау эдiсi болып табылады, сонымен ;атар КТ, МРТ, ERCP ас;ынуларды аны;тау Yшiн ;олданылатын эдстер болып табылады. Сонымен ;атар, эртYрлi хирургиялы; эдстер антипаразиттк терапиямен бiрiктiрiлген бауыр эхинококкозыныц ;аутн жэне ;айталануын азайтады.
Современные подходы в диагностике и лечении кистозного эхинококкоза печени. Обзор литературы
Нагасбеков М.С.12, Баймаханов Ж.Б.12, Нурланбаев Е.К.12, Каниев Ш.А.12, Чорманов А.Т.12, Баймаханов Ж.Б.12
1 АО «Национальный научный центр хирургии им. А.Н. Сызганова», г. Алматы, Республика Казахстан
2 НАО «Казахский национальный медицинский университет им. С.Д. Асфендиярова», г. Алматы, Республика Казахстан
Аннотация
Эхинококкоз печени - тяжелое зоонозное заболевание космополитической природы, вызываемое цестодами рода Echinococcus семейства Taeniidae, приводящее к кистозному и альвеолярному эхинококкозу, формирующему значительную проблему здравоохранения во всем мире.
Цель работы - анализ литературного обзора современных подходов в диагностике и лечении кистозного эхинококкоза печени.
Материал и методы. Мы систематически искали литературу и выбрали источники из MEDLINE, PubMed, Scopus, Elsevier, E-library, GoogleScholar, а также исследовательские работы и образовательные онлайн-публикации на разных языках. Были включены 43 статьи, отвечающие критериям включения.
Результаты. В обзорной статье представлены эпидемиология, методы диагностики и лечения кистозного эхинококка печени.
Вывод. Таким образом, среди современных подходов в диагностике кистозного эхинококкоза печени методом выбора является УЗИ, а для выявления осложнений используются КТ, МРТ, ЭРХПГ. Кроме того, различные хирургические методы в сочетании с антипаразитарной терапией снижают риск и рецидивы кистозного эхинококкоза печени.
Автор для корреспонденции: Нагасбеков М.С. - Докторант PhD, врач хирург АО «ННЦХ им. А.Н. Сызганова» г. Алматы, Казахстан E-mail: nagasbekov@inbox.ru
Конфликт интересов
Авторы заявляют об отсутствии конфликта интересов
Ключевые слова:
эхинококковая киста, гидатидоз печени, PAIR, альбендазол, перицистэктомия
Introduction
Liver echinococcosis (LE) is a severe zoonotic disease caused by cestodes of the genus Echinococcus from the family Taeniidae, affecting both humans and animals, consisting of eight currently recognized species and one genotypic cluster - Echinococcus canadensis. This pathology has a cosmopolitan nature and occurs in all continents of the globe except Antarctica [1]. The most dangerous and serious problem for public health are: Echinococcus granulosus and Echinococcus multilocularis, which cause cystic and alveolar echinococcosis, respectively [2].
Alveolar echinococcosis (AE) or alveococcosis, caused by Echinococcus multilocularis, causes a tumor-like liver disease that is widespread throughout the northern hemisphere of the globe, in parts of Asia and in southern regions of Tibet, and is an extremely serious disease that is associated with significant loss of life mainly due to the lack of treatment options. The life cycle of this pathology is associated with wildlife, with carnivorous canids, usually foxes, as the definitive hosts and various rodent species as intermediate hosts. However, dogs and cats can also serve as competent definitive hosts [3-4].
Cystic liver echinococcosis (CE) or hydatidosis is a cosmopolitan parasitic disease of humans and animals caused by infection with Echinococcus granulosus, the main sources of which are canines [5]. Like other cestodes, CE has intermediate and definitive hosts. Dogs are the definitive hosts, and mammalian ruminants are intermediate carriers of this tapeworm [6].
Studies have shown that CE is a serious problem in the Mediterranean countries with high prevalence in Spain, parts of Italy, Greece and Turkey [7], as well as Central Asian countries: Kyrgyzstan, Tajikistan, Turkmenistan and Uzbekistan [8]. In Africa, there is an active transmission of Echinococcus granulosus between humans and animals (including wild animals) in countries: Libya, Tunisia, Algeria and Morocco [6]. In the countries of South America: in Argentina, Brazil, Chile, Peru and Uruguay, 5 thousand cases of CE are diagnosed every year [9].
Echinococcal cysts can be localized in almost any human tissue and organs, but most often affect the liver [10]. The lethal outcome from this pathology is associated with the development of many complications which accounts for 2-4% [11]. Due to the paucity of manifestations of clinical signs, CE is detected incidentally, mostly during routine check-ups [12].
Complications of CE include: allergic and anaphy-lactic reactions to dissemination of contents into the abdominal cavity; breakthrough into the biliary system with cholangitis and with or without obstructive jaundice; into the pleural cavity or into the lung, causing pleural echinococcosis or bronchial fistula [13].
Despite wide range of diagnostic and treatment modalities, there is yet no standardized protocol. This review aims to provide up-to-date information on the diagnosis and treatment of hepatic cystic echinococ-cosis in light of the available data.
Microbiology of the parasite:
Echinococcus granulosus is a small sized tape-
worm with various genotypes. Molecular biology has identified 10 genetic types within E. granulosus [14]. These are G1 and G2 - two lines of sheep; G3 and G4 - two lines of cattle; G4 horse line; G6 - camel line; G7 - pig line; G8 - cervid line; G9 - genotype in pigs in Poland; G10 - a line of reindeer in Eurasia. Of these, G1 is the most dangerous and endemic, most often associated with human infections [14].
There are two hosts in the life cycle of all Echi-nococcus species. The first is the definitive host, and the second is the "intermediate host" where the hydatid arises. The definitive hosts include cats, dogs, wolves and foxes. The adult worm is present in the intestines of the definitive hosts, causing intestinal parasitosis, the lifespan of which in the intestines of dogs is about 5 months and is excreted in the faeces [15]. Sheep and other herbivores become "intermediate hosts" when they eat grasses infested with these eggs. Humans are incidental hosts and do not play a significant role in the life cycle of Echinococcus, being an "intermediate host" for the parasite when they eat food contaminated with these eggs. The oncosphere, which comes out of the egg taken through the gastrointestinal tract, attaches to the intestinal wall with its hooks, then entering the bloodstream reaches the liver first. Thus, the most common site of injury in humans is the liver, which accounts for 50-70% of cases, followed by the lungs (20-30%), less often the spleen, kidneys, heart, bones, central nervous system, etc. organs [1315]. The embryo loses its scolex when it enters the organ and takes the form of a cyst consisting of an exo-cyst and an endocyst. Inside the cyst there is a sterile transparent liquid, and outside there is fibrous capsule which is a granulomatous inflammatory reaction, that leads to the cyst being blocked by fibrous tissue [16].
Epidemiology in the world
Developed natural livestock farming, low socio-economic status, regional climate, as well as uncontrolled and unhygienic slaughter of animals increase morbidity. According to the World Health Organization (WHO), E. granulosus is endemic in South America, Eastern Europe, Russia, the Middle East and China, where the incidence rate among humans reaches 50 per 100,000 population [10, 13]. CE is also endemic in the Mediterranean countries with a high prevalence in Spain, Italy, Greece and Turkey, and in Central Asia: Kyrgyzstan, Tajikistan, Turkmenistan and Uzbekistan. In Africa, there is an active transmission of Echinococcus gran-ulosus between humans and animals (including wild animals) in the countries: Libya, Tunisia, Algeria and Morocco. In South American countries: in Argentina, Brazil, Chile, Peru and Uruguay, 5,000 cases of CE are diagnosed annually [17].
Epidemiology in Kazakhstan
The Republic of Kazakhstan is an endemic region for echinococcosis with high incidence rates. It is estimated that in Kazakhstan, the prevalence of infection among sheep ranges from 20% to 25% among sheep aged 1 year and 74%-80% among sheep aged 6 years and older. Among wild and rural dogs, the prevalence of infection is 23% and 6%, respectively. Human infection has increased since the mid-1990s [17, 18]. The average yearly incidence in the country from 1974 to
1994 went up from 0.9 to 1.4 per 100,000 population. From 1995 to 2000, it increased from 1.4 to 5.9 cas-es.According to the results of research for the period from 2007 to 2016, in most regions of Kazakhstan, the incidence of CE dropped from 5.6 to 4.7 per 100 thousand population, respectively. A higher incidence was noted in the south of Kazakhstan, with the incidence rate from 7.0 to 10.5 cases per 100,000 population. We analyzed the primary incidence of liver echinococcosis in the Republic of Kazakhstan for 2018 - 2020. During the study period, 2,248 patients with LE aged 15 to 70 years were registered. The analysis revealed a decrease in morbidity over 3 years by 2.03 = from 5.77 to 3.74, however in the south of the country, morbidity rates remain at a high level [19].
Ultrasound in diagnostics
Liver CE is mainly diagnosed by ultrasound examination (ultrasound). It is the simplest method due to its accessibility and the safest due to its noninvasiveness and lack of radiation, and is also preferred for determining the stage, differential diagnosis and follow-up of most cystic lesions of the abdominal cavity [20-22]. Ultrasound is also an imaging tool for minimally invasive percutaneous interventions in interventional treatment of CE [23].
The particular significance of ultrasound is that portable ultrasound is important as a screening tool [24].
For questionable cysts, serology may be useful for differentiation. Although ultrasound is the method of choice for determining the stage and number of cysts, as well as the degree of the disease, computed tomography (CT) and magnetic resonance imaging (MRI) are useful under certain circumstances [25].
Computed tomography (CT)
CT is indicated in cases where there are difficulties in diagnosis by ultrasound in patients with excessive subcutaneous fat, and is also effective for assessing postoperative changes - calcification of cysts [25]. Calcification of the cyst occurs not only in inactive cysts in the late stage, but can develop in all stages.
CT with contrast is crucial in the differential diagnosis of focal liver lesions [26]. CT is often used to monitor the effectiveness of PAIR (Puncture, Aspiration, Injection of protoscolicidal agent and Reaspiration) in remote periods [19, 25].
Magnetic resonance imaging (MRI)
In complications associated with the breakthrough of echinococcal cysts into the bile ducts, MR cholangi-ography is the most preferable, moreover MRI can be used when ultrasound is not informative enough, and CT is contraindicated [19. 25]. MRI has a high sensitivity for detecting CE, especially for identifying the number of cysts, their size, location and relationship with neighboring structures. MR cholangiography is comparable to endoscopic retrograde cholangiography, for the assessment of cystobiliary fistulas [27].
Drug therapy
Antiparasitic therapy and CE surgical treatment complement each other and require an individual approach. Drug therapy is required for all patients after surgical treatment to prevent relapses.
Nowadays, albendazole (ABZ) is used in clinical
practice as the main drug for drug therapy of echinococcosis [28]. The daily dose ranges from 10 to 20 mg / kg. The duration of one continuous treatment cycle is from 21-60 days to several years, the number of cycles is 1-20 or more, the intervals between cycles are from 21 to 30 days. Also, this drug is used to reduce the risk of dissemination in PAIR and prevent relapse [19].
Operative method of treatment
In the modern world, minimally invasive interventions are becoming increasingly used in clinical practice: laparoscopic pericystectomies, percutaneous with ultrasound navigation and mini-access operations [19].
PAIR (punction, aspiration, injection, reaspiration).
Percutaneous puncture method of CE treatment under ultrasound guidance is designated by the abbreviation PAIR. This method is performed under en-dotracheal anesthesia due to the potentially high risk of anaphylactic reaction [28]. The advantages of PAIR are low traumatism, the possibility of numerous repetition of the procedure, the possibility of performing the procedure under local anesthesia in certain cases, and a shorter stay of patients in the postoperative period [19, 28].
The disadvantages of the percutaneous PAIR method are: the difficulty of evacuating the dense contents of the cyst in the presence of daughter cysts; the difficulties of complete fragmentation and removal of the chitinous membrane, the inability to remove the fibrous membrane, the danger of hemorrhagic complications during puncture [29].
Contraindications to PAIR:
• cyst infection;
• superficially located cysts,
• biliary fistulas;
• cysts localized in dangerous or hard-to-reach areas of the liver.
Injection of antiparasitic agents with PAIR includes the following solutions: 30% NaCl solution and 95% ethyl alcohol. Prevention with albendazole before and after PAIR is mandatory [19, 30].
According to Smego et al [31], 769 patients treated with ABZ + PAIR were compared with 952 patients treated surgically only. The conclusion from this study is that PAIR + ABZ is more effective than surgery and is associated with lower morbidity and mortality rates, reduced risk of relapse and shorter hospital stay.
Laparoscopic cholecystectomy
Laparoscopic surgery with CE is a technically complex surgical procedure. These surgical interventions are carried out only in specialized hepatopancreatobi-liary centers with properly adapted equipment for this. For the first time, a laparoscopic approach for liver CE was applied in 1992 [32].
Advantages of laparoscopic access:
• shorter stay in the postoperative period;
• low risk of wound infections;
• less need for analgesics in the postoperative period [6].
Disadvantages:
• difficulties with access to cysts localized in the posterior sector;
• increased risk of contamination leakage [33].
Systemic allergic and anaphylactic reactions, sometimes up to coma, are not uncommon in the case of hydatid fluid on the peritoneum [34].
Open echinococcotomy (endocystectomy)
Radical operations aimed at liver CE repair include pericystectomy and liver resection, whereas endocys-tectomy is the removal of cyst contents and sterilization of the residual cavity with scolexide solutions in combination with partial cystectomy [19].
Endocystectomy is performed mainly with large cysts adjacent to large tubular structures, when it is impossible to perform pericystectomy, as well as in cases where there is suppuration of the cyst with abscessing [34]. Leaving a fibrous capsule increases the risk of postoperative complications and the risk of relapse of the disease [19, 34].
Many methods of treatment of the residual cavity are described: omentoplasty, capitation and external drainage, or synthetic fibrin. In a retrospective study of Baliket al with 304 patients [35], it was shown that external drainage has a significantly higher level of complications, such as infection of the residual cavity and the formation of bile fistulas.
We found only one randomized trial that compared radical surgery with conservative surgery. The conclusion was that conservative surgery leads to a significantly higher frequency of early relapses compared to radical surgery [36].
Pericystectomy
Pericystectomy is the total removal of an echino-coccal cyst with a fibrous capsule [19, 36-37]. When the echinococcal cyst is mobilized and the fibrous capsule is isolated from the liver parenchyma in order to prevent complications, all tubular structures are carefully ligated and clipped. Excision of a parasitic cyst with a fibrous capsule (pericystectomy) is indicated for complicated forms of echinococcosis, especially with significant calcification of the fibrous capsule of the parasite. Complete removal of a cyst with a fibrous capsule is a more radical intervention, for it more reliably prevents relapses of the disease, and modern methods of hemostasis during surgery allow for intervention with minimal blood loss [37].
Total pericystectomy has long been considered the "gold standard" of CE treatment [38]. Radical resection of the liver for CE in comparison with partial cystectomy is safer in terms of complications and relapses [39].
Liver resection
Liver resection in echinococcosis is the most radical operation that provides the best guarantee against the occurrence of relapses of the disease [34]. Resection interventions have their advantages and disadvantages, the choice of technique is made by a specialist. In atypical operations, when only the affected area is excised and most of the liver is preserved, there is still a risk of bleeding.
Complications
Intraperitoneal rupture and breakthrough is the most common complication of CE and occurs in 3-17% of cases [40], as well as a breakthrough into the bile ducts [41]. Endoscopic retrograde cholangiopan-creatography (ERCP) determines the presence of a cystobiliary fistula for choosing the treatment in the
pre- and postoperative periods. Endoscopic sphinc-terotomy for surgical treatment of large-diameter cysts can lower the frequency of postoperative biliary fistulas from 11.1% to 7.6% [41], and in the postoperative period it can also provide possibility to treat postoperative biliary fistulas [42].
Postoperative period
Follow-up in the early and late postoperative period is recommended for the first month, third month, sixth month and twelfth month in the first year, and then every six months for the following two years, and then once a year, depending on the relevant clinical conditions. With CE, it is challenging to estimate the frequency of relapses. Therefore, ultrasound monitoring is sometimes carried out for up to ten years, during
References
1. Woolsey, I. D., & Miller, A. L. (2021). Echinococcus granulosussensulato and Echinococcus multilocularis: A review. Research inveterinary science, 135, 517-522. https://doi.org/10.1016/j. rvsc.2020.11.010
2. Deplazes, P., Rinaldi, L., Alvarez Rojas, C. A., Torgerson, P. R., Harandi, M. F., Romig, T., Antolova, D., Schurer, J. M., Lahmar, S., Cringoli, G., Magambo, J., Thompson, R. C., & Jenkins, E. J. (2017). Global Distribution of Alveolar and Cystic Echinococcosis. Advances in parasitology, 95, 315-493. https://doi.org/10.1016/ bs.apar.2016.11.001
3. Kapel, C. M., Torgerson, P. R., Thompson, R. C., &Deplazes, P. (2006). Reproductive potential of Echinococcus multilocularis in experimentally infected foxes, dogs, raccoon dogs and cats. Internationa ljournal for parasitology, 36(1), 7986. https://doi.org/10.1016Zj.ijpara.2005.08.012
4. Lundström-Stadelmann, B., Rufener, R., & Hemphill, A. (2020). Drug repurposing applied: Activity of the anti-malarial mefloquine against Echinococcus multilocularis. International journal for parasitology. Drugs and drug resistance, 13, 121-129. https://doi.org/10.1016/j. ijpddr.2020.06.002
5. Mihmanli, M., Idiz, U. O., Kaya, C., Demir, U., Bostanci, O., Omeroglu, S., & Bozkurt, E. (2016). Current status of diagnosis and treatment of hepatic echinococcosis. World journal of hepatology, 8(28), 1169-1181. https://doi. org/10.4254/wjh.v8.i28.1169
6. Gomez I Gavara, C., Löpez-Andüjar, R., Belda Ibanez, T., RamiaÄngel, J. M., Moya Herraiz, Ä.,Orbis Castellanos, F., ParejaIbars, E., & San Juan Rodriguez, F. (2015). Review of the treatment of liver hydatid cysts. World journal of gastroenterology, 21(1), 124-131. https://doi. org/10.3748/wjg.v21.i1.124
7. Dakkak A. (2010). Echinococcosis/hydatidosis: a severe threat in Mediterranean countries. Veterinary parasitology, 174(1-2), 2-11. https:// doi.org/10.1016/j.vetpar.2010.08.009
8. Casulli A. (2020). Recognising the substantial burden of neglected pandemics cystic and
which relapses have been reported, despite the treatment [23].
Conclusion
Antiparasitic therapy surpasses the placebo effect, but monotherapy is not effective with a separate application for each. Uncomplicated active cysts in stages C1 and C E3 a can be treated with PAIR + ABZ before and after surgery. Uncomplicated, inactive cysts (deceased echinococcosis) can be treated with a "watch and wait" strategy. Surgery is the primary choice in multivesicular cysts, as well as in the presence of cys-tobiliary fistulas. The combination of ABZ + surgical treatment is more advantageous in terms of relapse and complications [42].
alveolar echinococcosis. The Lancet. Global health, 8(4), e470-e471. https://doi.org/10.1016/ S2214-109X(20)30066-8
9. Pavletic, C. F., Larrieu, E., Guarnera, E. A., Casas, N., Irabedra, P., Ferreira, C., Sayes, J., Gavidia, C. M., Caldas, E., Lise, M. L. Z., Maxwell, M., Arezo, M., Navarro, A. M., Vigilato, M. A. N., Cosivi, O., Espinal, M., & Vilas, V. J. D. R. (2017). Cystic echinococcosis in South America: a call for action. Revistapanamericana de saludpublica = Pan American journal of public health, 41, e42. https://doi.org/10.26633/RPSP.2017.42
10. Brunetti, E., Kern, P., Vuitton, D. A., & Writing Panel for the WHO-IWGE (2010). Expert consensus for the diagnosis and treatment of cystic and alveolar echinococcosis in humans. Actatropica, 114(1), 1-16. https://doi. org/10.1016/j.actatropica.2009.11.001
11. Belhassen-García, M., Romero-Alegria, A., Velasco-Tirado, V., Alonso-Sardón, M., Lopez-Bernus, A., Alvela-Suarez, L., delVillar, L. P., Carpio-Perez, A., Galindo-Perez, I., Cordero-Sanchez, M., & Pardo-Lledias, J. (2014). Study of hydatidosis-attributed mortality in endemic area. PloS one, 9(3), e91342. https://doi.org/10.1371/ journal.pone.0091342
12. Manzano-Román, R., Sánchez-Ovejero, C., Hernández-González, A., Casulli, A., &Siles-Lucas, M. (2015). Serological Diagnosis and Follow-Up of Human Cystic Echinococcosis: A New Hope for the Future?. BioMed research international, 2015, 428205. https://doi. org/10.1155/2015/428205
13. Bhutani, N., &Kajal, P. (2018). Hepatic echinococcosis: A review. Annals of medicine and surgery (2012), 36, 99-105. https://doi. org/10.1016/j.amsu.2018.10.032
14. McManus, D. P., & Thompson, R. C. (2003). Molecular epidemiology of cystic echinococcosis. Parasitology, 127 Suppl, S37-S51. https://doi. org/10.1017/s0031182003003524
15. Romig, T., Deplazes, P., Jenkins, D., Giraudoux, P., Massolo, A., Craig, P. S., Wassermann, M., Takahashi, K., & de la Rue, M. (2017). Ecology and Life Cycle Patterns of Echinococcus Species.
Advances in parasitology, 95, 213-314. https:// doi.org/10.1016/bs.apar.2016.11.002
16. Rinaldi, F., Brunetti, E., Neumayr, A., Maestri, M., Goblirsch, S., &Tamarozzi, F. (2014). Cystic echinococcosis of the liver: A primer for hepatologists. World journal of hepatology, 6(5), 293-305. https://doi.org/10.4254/wjh.v6.i5.293
17. Grosso, G., Gruttadauria, S., Biondi, A., Marventano, S., &Mistretta, A. (2012). Worldwide epidemiology of liver hydatidosis including the Mediterranean area. World journal of gastroenterology, 18(13), 1425-1437. https://doi. org/10.3748/wjg.v18.i13.1425
18. Abdybekova, A; Sultanov, A; Karatayev, B; Zhumabayeva, A; Shapiyeva, Z; Yeshmuratov, T; Toksanbayev, D; Shalkeev, R; Torgerson, Paul R (2015). Epidemiology of echinococcosis in Kazakhstan: an update. Journal of Helminthology, 89(6):647-650. DOI: https://doi.org/10.1017/ S0022149X15000425
19. Nagasbekov M.S., Baimakhanov Z.B., Kaniyev S.A., Nurlanbayev E.K., Chormanov A.T., Baimakhanov B.B. Results of minimally invasive treatment of liver echinococcosis in comparison with traditional surgical methods. Annaly khirurgicheskoygepatologii = Annals of HPB Surgery. 2021;26(4):61-68. (In Russ.) https://doi. org/10.16931/1995-5464.2021-4-61-68
20. Moro, P., & Schantz, P. M. (2009). Echinococcosis: a review. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 13(2), 125-133. https://doi.org/10.1016/j. ijid.2008.03.037
21. Brunetti, E., Tamarozzi, F., Macpherson, C., Filice, C., Piontek, M. S., Kabaalioglu, A., Dong, Y., Atkinson, N., Richter, J., SchreiberDietrich, D., & Dietrich, C. F. (2018). Ultrasound and Cystic Echinococcosis. Ultrasound international open, 4(3), E70-E78. https://doi. org/10.1055/a-0650-3807
22. WHO Informal Working Group (2003). International classification of ultrasound images in cystic echinococcosis for application in clinical and field epidemiological settings. Actatropica, 85(2), 253-261. https://doi.org/10.1016/s0001-706x(02)00223-1
23. Brunetti, E., Kern, P., Vuitton, D. A., & Writing Panel for the WHO-IWGE (2010). Expert consensus for the diagnosis and treatment of cystic and alveolar echinococcosis in humans. Actatropica, 114(1), 1-16. https://doi. org/10.1016/j.actatropica.2009.11.001
24. Macpherson, C. N., Bartholomot, B., &Frider, B. (2003). Application of ultrasound in diagnosis, treatment, epidemiology, public health and control of Echinococcusgranulosus and E. multilocularis. Parasitology, 127 Suppl, S21-S35. https://doi. org/10.1017/s0031182003003676
25. Brunetti, E., Tamarozzi, F., Macpherson, C., Filice, C., Piontek, M. S., Kabaalioglu, A., Dong, Y., Atkinson, N., Richter, J., SchreiberDietrich, D., & Dietrich, C. F. (2018). Ultrasound
and Cystic Echinococcosis. Ultrasound international open, 4(3), E70-E78. https://doi. org/10.1055/a-0650-3807
26. Chiorean, L., Caraiani, C., Radzina, M., Jedrzejczyk, M., Schreiber-Dietrich, D., & Dietrich, C. F. (2015). Vascular phases in imaging and their role in focal liver lesions assessment. Clinical hemorheology and microcirculation, 62(4), 299326. https://doi.org/10.3233/CH-151971
27. Ignee, A., Baum, U., Schuessler, G., & Dietrich,
C. F. (2009). Contrast-enhanced ultrasound-guided percutaneous cholangiography and cholangiodrainage (CEUS-PTCD). Endoscopy, 41(8), 725-726. https://doi. org/10.1055/s-0029-1214956
28. Akhan O., Salik A.E., Ciftci T., Akinci D., Islim F., Akpinar B. Comparison of Long-Term Results of Percutaneous Treatment Techniques for Hepatic Cystic Echinococcosis Types 2 and 3b. AJR Am. J.Roentgenol. 2017;208(4):878-884. doi:10.2214/ AJR.16.16131
29. Sozuer, E., Akyuz, M., &Akbulut, S. (2014). Open surgery for hepatic hydatid disease. International surgery, 99(6), 764-769. https://doi.org/10.9738/ INTSURG-D-14-00069.1
30. Nunnari, G., Pinzone, M. R., Gruttadauria, S., Celesia, B. M., Madeddu, G., Malaguarnera, G., Pavone, P., Cappellani, A., &Cacopardo, B. (2012). Hepatic echinococcosis: clinical and therapeutic aspects. World journal of gastroenterology, 18(13), 1448-1458. https://doi. org/10.3748/wjg.v18.i13.1448
31. Smego, R. A., Jr, Bhatti, S., Khaliq, A. A., & Beg, M. A. (2003). Percutaneous aspiration-injection-reaspiration drainage plus albendazole or mebendazole for hepatic cystic echinococcosis: a meta-analysis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 37(8), 1073-1083. https://doi. org/10.1086/378275
32. Katkhouda, N., Fabiani, P., Benizri, E., &Mouiel, J. (1992). Laser resection of a liver hydatid cyst under videolaparoscopy. The British journal ofsurgery, 79(6), 560-561. https://doi. org/10.1002/bjs.1800790628
33. Dziri, C., Haouet, K., & Fingerhut, A. (2004). Treatment of hydatid cyst of the liver: where is the evidence?. World journal of surgery, 28(8), 731736. https://doi.org/10.1007/s00268-004-7516-z
34. Kaniyev S.A., Baimakhanov Z.B., Doskhanov M.O., Nurlanbayev Y.K., Serikuly E., Birzhanbekov N.N., Skakbayev A.S., Baiguisova
D.Z., Barlybai R.A., Sadykov C.T., Musakhanova Z.Z., Turgan A.G., Chormanov A.T., Kausova G.K., Medeubekov U.S., Seisenbayev M.A., Baimakhanov B.B. Current approaches to liver echinococcosis management (review). Annaly khirurgicheskoy gepatologii = Annals of HPB Surgery. 2018;23(3):47-56. (In Russ.) https://doi. org/10.16931/1995-5464.2018347-56
35. Balik, A. A., Ba§oglu, M., Celebi, F., Oren, D., Polat, K. Y., Atamanalp, S. S., &Akgay, M. N. (1999). Surgical treatment of hydatid disease of
the liver: review of 304 cases. Archives of surgery (Chicago, Ill. : 1960), 134(2), 166-169. https://doi. org/10.1001/archsurg.134.2.166
36. Yuksel, O., Akyurek, N., Sahin, T., Salman, B., Azili, C., &Bostanci, H. (2008). Efficacy of radical surgery in preventing early local recurrence and cavity-related complications in hydatic liver disease. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract, 12(3), 483-489. https://doi. org/10.1007/s11605-007-0301-1
37. Kaniev Sh.A., Baimakhanov Zh.B., Doskhanov M.O., Nurlanbaev E.K., Serikuly E., Birzhanbekov N.N., Skakbaev A.S., Baiguisova D.Z., Barlybay R A.A., SadykovCh.T., Chormanov A.T., Kausova G.K., MedeubekovU.Sh., Seisembaev M.A., Baimakhanov B.B. Results of surgical and drug treatment of liver echinococcosis. Vestnik khirurgii Kazahstana =Bulletin of surgery of Kazakhstan. 2018; 3 (56): 29-33. (In Russian)
38. Bhutani, N., &Kajal, P. (2018). Hepatic echinococcosis: A review. Annals of medicine and surgery (2012), 36, 99-105. https://doi. org/10.1016/j.amsu.2018.10.032
39. Junghanss, T., da Silva, A. M., Horton, J.,
Chiodini, P. L., & Brunetti, E. (2008). Clinical management of cystic echinococcosis: state of the art, problems, and perspectives. The American journal of tropical medicine and hygiene, 79(3), 301-311.
40. Kumar, R., Reddy, S. N., &Thulkar, S. (2002). Intrabiliary rupture of hydatid cyst: diagnosis with MRI and hepatobiliary isotope study. The British journal of radiology, 75(891), 271-274. https:// doi.org/10.1259/bjr.75.891.750271
41. Sharma, B. C., Reddy, R. S., & Garg, V. (2012). Endoscopic management of hepatic hydatid cyst with biliary communication. Digestive endoscopy:official journal of the Japan Gastroenterological Endoscopy Society, 24(4), 267-270. https://doi.org/10.1111Zj.1443-1661.2011.01225.x
42. Dolay, K., &Akbulut, S. (2014). Role of endoscopic retrograde cholangiopancreatography in the management of hepatic hydatid disease. World journal of gastroenterology, 20(41), 1525315261. https://doi.org/10.3748/wjg.v20.i41.15253 Available at: http://www.cebm.net/oxford-centre-evidence-based-medicine-levels-evidence-march-2009/.
